The Week Ahead : 23rd- 27th March 2026
Highlights: Narrative Drive Market, T2108 Oversold
Sources & Services I Use in my Trading:
StockAnalysis.com - I’ve been using Stock Analysis as a super cheap but reliable method of looking at New and Upcoming IPOs, Earnings Calendars and most notably KPIs (Key Performance Indicators). Stock Analysis allows you to view the KPIs for many companies with up to date metrics and segments that you can cross reference against Earnings Results. This is incredibly important when understanding what metrics move a stock. At $65 per year it’s a no brainer. They’ve given me a discount code if you use IRISHBORNINVESTOR they will give you another 10% Off.
Week Overview
Market Setup: Below All Moving Averages, Strong VIX, Panic Setting In
Key Themes: Oversold Bounce
Focus Areas: This is a very slow week in terms of earnings and catalysts. US PMIs on Tuesday likely the most important on the macro front. We’re in a fully news driven market right now. Focused on Trump’s every word and threat. My main focus this week will be an oversold bounce. T2108 (% of Stocks under the 40MA) is below 20. It closed at 16. When this drops below 10 then the market and individual stocks tend to rebound sharply in the short term. During these periods everything is correlated. Stock picking is less important in the short term.
Whether this is a short term bounce or the beginning of a sustained upward move is anyone’s guess. The best situation is likely a strong gap down on Monday but we probably won’t be that lucky..
Earnings below, some reasonable charts but nothing that I’m super excited about considering the conditions. There are some Biotech’s also reporting data listed below.
Caution advised this week. Less is more for sure.
Macro Events (Eastern Time)
Major Economic Events this week.
Monday March 23 2026
07:30 AM - Chicago Fed National Activity Index FEB (Previous: 0.18, Consensus: 0.27)
Tuesday March 24 2026
07:15 AM - ADP Employment Change Weekly (Consensus: 9K)
08:45 AM - S&P Global Composite PMI Flash MAR (Previous: 51.9, Consensus: 50.5)
08:45 AM - S&P Global Manufacturing PMI Flash MAR (Previous: 51.6, Consensus: 50.2)
08:45 AM - S&P Global Services PMI Flash MAR (Previous: 51.7, Consensus: 50.4)
03:30 PM - API Crude Oil Stock Change MAR/20 (Previous: 6.6M)
05:30 PM - Fed Barr Speech
Wednesday March 25 2026
06:00 AM - MBA 30-Year Mortgage Rate MAR/20 (Previous: 6.3%)
07:30 AM - Current Account Q4 (Previous: -$226.4B, Consensus: -$235.0B)
07:30 AM - Export Prices MoM FEB (Previous: 0.6%, Consensus: 0.5%)
07:30 AM - Import Prices MoM FEB (Previous: 0.2%, Consensus: 0.1%)
09:30 AM - EIA Crude Oil Stocks Change MAR/20 (Previous: 6.156M)
09:30 AM - EIA Gasoline Stocks Change MAR/20 (Previous: -5.436M)
03:10 PM - Fed Miran Speech
Thursday March 26 2026
07:30 AM - Initial Jobless Claims MAR/21 (Previous: 205K, Consensus: 209.0K)
03:00 PM - Fed Cook Speech
05:30 PM - Fed Miran Speech
06:00 PM - Fed Jefferson Speech
06:10 PM - Fed Barr Speech
Friday March 27 2026
09:00 AM - Michigan Consumer Sentiment Final MAR (Previous: 56.6, Consensus: 55.5)
10:30 AM - Fed Daly Speech
Earnings Highlights
Monday Before Open: LAR
Monday After Hours: ABVX
Tuesday Before Open: HSAI
Tuesday After Hours: NOAH, GME, VELO
Wednesday Before Open: ONDS, KALV, CGNT, KC, SY, WDH
Wednesday After Hours: KRMN, HIT, CELC, QTI
Thursday After Hours: CV, IRIX
Full Earnings Watchlist: TradingView Link
Biotech Catalysts
Upcoming: ANVS, NKGN, RCKT, IFRX, CNTB, NKTR, KYMR, ALMS, MRK, REVB, IDYA, KPTI, ANRO, ALZN, WVE, OCGN, OKUR, APGE, BEAM, INSM, VRDN, KOD, PEPG, IOVA, LSTA, SNDX, PCSA, IMAB, ONCY, NVCR, SRPT, PALI, ORIC, ENTX, ANTX, NMRA, ZLDPF, GUTS
March 28–30
RCKT — KRESLADI PDUFA decision (LAD-I) — March 28
IFRX — Vilobelimab Ph3 PG late-breaking oral at AAD 2026 — March 28
CNTB — Rademikibart RADIANT-AD Ph3 results at AAD 2026 — March 28
NKTR — Rezpegaldesleukin REZOLVE-AA Ph2b 36-week results at AAD 2026 — March 28
KYMR — KT-621 BroADen Ph1b AD data at AAD 2026 — March 28
ALMS — ESK-001 Ph3 ONWARD1/2 24-week oral at AAD 2026 — March 28
MRK — Enlicitide Decanoate CORALreef Lipids/HeFH durability data at ACC.26 — March 29
REVB — Gemini Ph1 CKD/AKI data presented — March 29–April 1
ACC Annual Scientific Session — March 28–30
End of March / Late Q1 (unspecified date)
IDYA — OptimUM-02 Ph2/3 median PFS topline (~last week of March)
KPTI — SENTRY Ph3 myelofibrosis topline data
ANRO — ALTO-101 Ph2 CIAS topline (end of Q1)
ALZN — AL001 healthy-subjects topline (end of March)
WVE — WVE-007 INLIGHT Ph1 obesity data (March)
OCGN — OCU410 ArMaDa Ph2 full dataset (March)
OKUR — OKI-219 Ph1 PIKture-01 updated data (March)
Q1 2026 (Broader Window — Imminent)
APGE — APG777 APEX Part A 52-week AD data
BEAM — BEAM-302 Ph1/2 AATD updated data + pivotal plan
INSM — Brensocatib CEDAR Ph2b interim futility analysis
VRDN — VRDN-003 REVEAL-1 Ph3 topline (TED)
KOD — Tarcocimab GLOW2 Ph3 topline (diabetic retinopathy)
PEPG — PGN-EDODM1 FREEDOM2 5mg/kg data
IOVA — IOV-4001 Ph1/2 melanoma results
LSTA — ASCEND Ph2b final data + iLSTA Ph1/2 final data
SNDX — Revumenib Ph1/2 colorectal cancer data
PCSA — PCS6422 Ph2 interim (breast cancer)
IMAB — Givastomig combo Ph1b gastric cancer topline
ONCY — GOBLET Cohort 5 interim (pancreatic)
NVCR — PANOVA-4 Ph2 topline (pancreatic)
SRPT — SRP-1003 (DM1) + SRP-1001 (FSHD) Ph1/2 readouts
PALI — PALI-2108 Ph1b safety/PK/PD topline (Crohn's)
ORIC — Rinzimetostat Ph1b dose optimisation data (mCRPC)
ENTX — Next-Gen EB613 Ph1 bridging results
CNTB — Rademikibart Ph1b bronchoconstriction + acute airway data (two studies)
ANTX — AN2-502998 Ph1 FIH initial data (Chagas)
ANRO — ALTO-101 Ph2 CIAS (also listed above)
NMRA — NMRA-861 Ph1 data (schizophrenia)
ZLDPF — Petrelintide Ph2 obesity data
GUTS — Revita REMAIN-1 6-month midpoint data
Note: Never front-run biotech catalysts. Wait for the catalyst to hit, then assess if the reaction is tradable. Dates are estimates and can shift.
Full Q1 Biotech Watchlist: TradingView Link
Delayed Reaction Watchlist:
Monitoring:
TSSI
Have a Great Week!
Born Investor
PS: There are many ways to trade stocks in play. It does not have to be the one that keeps going straight up and sometimes it doesn’t even have to be day one of the catalyst. Everyone must find a setup, timeframe and method that works for them. This list is supposed to educate on the criteria I use and the methods in which I find Stocks in Play. Yours may differ and that is completely okay.
